Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 27:11:1193204.
doi: 10.3389/fbioe.2023.1193204. eCollection 2023.

Preclinical in vitro evaluation of implantable materials: conventional approaches, new models and future directions

Affiliations
Review

Preclinical in vitro evaluation of implantable materials: conventional approaches, new models and future directions

Emilie Frisch et al. Front Bioeng Biotechnol. .

Abstract

Nowadays, implants and prostheses are widely used to repair damaged tissues or to treat different diseases, but their use is associated with the risk of infection, inflammation and finally rejection. To address these issues, new antimicrobial and anti-inflammatory materials are being developed. Aforementioned materials require their thorough preclinical testing before clinical applications can be envisaged. Although many researchers are currently working on new in vitro tissues for drug screening and tissue replacement, in vitro models for evaluation of new biomaterials are just emerging and are extremely rare. In this context, there is an increased need for advanced in vitro models, which would best recapitulate the in vivo environment, limiting animal experimentation and adapted to the multitude of these materials. Here, we overview currently available preclinical methods and models for biological in vitro evaluation of new biomaterials. We describe several biological tests used in biocompatibility assessment, which is a primordial step in new material's development, and discuss existing challenges in this field. In the second part, the emphasis is made on the development of new 3D models and approaches for preclinical evaluation of biomaterials. The third part focuses on the main parameters to consider to achieve the optimal conditions for evaluating biocompatibility; we also overview differences in regulations across different geographical regions and regulatory systems. Finally, we discuss future directions for the development of innovative biomaterial-related assays: in silico models, dynamic testing models, complex multicellular and multiple organ systems, as well as patient-specific personalized testing approaches.

Keywords: 3D models; biocompatibility; biomaterials; implants; organoids.

PubMed Disclaimer

Conflict of interest statement

Authors AB, NV, and PL are employed by the company SPARTHA Medical. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Evolution of biocompatibility testing: from classic monolayer culture to personalized testing approaches.
FIGURE 2
FIGURE 2
Foreign body reaction to biomaterial implantation and respective evaluation. Quickly after the implantation of the biomaterial, blood plasma proteins are adsorbed on the surface of the material. Their presence on the implant allows recruitment of leukocytes, including neutrophils and followed by monocytes. Differentiation of monocytes into macrophages and then their fusion into foreign body giant cells (FBGC) finally lead to recruitment of fibroblasts and to formation of a fibrous capsule around the implant, leading to chronic inflammation. Each of the foreign body reaction steps can be assessed through more or less specific assays. Enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), microscopy or flow cytometry are common methods to study biocompatibility. In addition to these, there are more specific tests such as Griess assay for nitric oxide secretion, Cytoselect™ 96-well phagocytosis assay to study the activation of macrophages, or Epithelial to Mesenchymal Transition (EMT) and Fibroblast to Myofibroblast Transition (FMT) to study the fibrotic tissue formation.
FIGURE 3
FIGURE 3
Evaluation of materials cytotoxicity (A) and cell adhesion (B) in 2D and 3D environment. In 2D, only one cell layer is in contact with the material, which may lead to an overestimation of its toxicity, as compared with 3D model. In a similar way, material interaction with the surrounding tissues is more complex in 3D, with the cells surrounding the implant from all the sides.
FIGURE 4
FIGURE 4
Engineered oral mucosal models with inserted implant materials (A) and histological views of oral mucosal models (B). Adapted from (Barker et al., 2020). Copyright 2020, the Authors. Published by MDPI, Basel, Switzerland.
FIGURE 5
FIGURE 5
Schematics showing the experimental steps for construction of in vitro 3D skin model using gelatin methacrylate (GelMA) scaffold Adapted from (Kwak et al., 2018). Copyright 2018, Elsevier.
FIGURE 6
FIGURE 6
Parameters to consider for medical device testing biocompatibility. Main parameters have been classified into 4 categories related to the sample selection, testing methods, their applications and standardization.

Similar articles

Cited by

References

    1. Ahn S. I., Kim Y. (2021). Human blood–brain barrier on a chip: Featuring unique multicellular cooperation in pathophysiology. Trends Biotechnol. 39 (8), 749–752. 10.1016/j.tibtech.2021.01.010 - DOI - PubMed
    1. Akiva A., Melke J., Ansari S., Liv N., van der Meijden R., van Erp M., et al. (2021). An organoid for woven bone. Adv. Funct. Mater. 31 (17), 2010524. 10.1002/adfm.202010524 - DOI
    1. Alcaide M., Serrano M. C., Pagani R., Sánchez-Salcedo S., Nieto A., Vallet-Regí M., et al. (2009). L929 fibroblast and Saos-2 osteoblast response to hydroxyapatite-βTCP/agarose biomaterial. J. Biomed. Mater. Res. Part A 89A (2), 539–549. 10.1002/jbm.a.31985 - DOI - PubMed
    1. Anderson J. M., Rodriguez A., Chang D. T. (2008). Foreign body reaction to biomaterials. Seminars Immunol. 20 (2), 86–100. 10.1016/j.smim.2007.11.004 - DOI - PMC - PubMed
    1. Azqueta A., Dusinska M. (2015). The use of the comet assay for the evaluation of the genotoxicity of nanomaterials. Front. Genet. 6, 239. 10.3389/fgene.2015.00239 - DOI - PMC - PubMed

LinkOut - more resources